Tilray Brands (TLRY) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
22 Dec, 2025Executive summary
Achieved record Q1 net revenue of $210 million, up 5% year-over-year, with net income of $1.5 million and EPS of zero, marking a return to profitability from a prior year net loss of $34.7 million.
Adjusted EBITDA rose 9% year-over-year to $10.2 million, supported by organic growth, cost-saving initiatives, and Project 420, which delivered $25.1 million in cumulative savings.
Revenue growth was driven by strong performance in Canadian adult-use and international cannabis, as well as distribution and wellness, while beverage revenue remained flat due to SKU optimization.
Strengthened balance sheet by reducing outstanding debt by $7.7 million, ending the quarter with $265 million in cash and a net debt-to-EBITDA ratio of 0.07x.
Maintained leadership in Canadian cannabis, expanded international presence, and continued innovation in beverage and wellness segments.
Financial highlights
Net revenue reached $210 million, a 5% increase year-over-year.
Cannabis revenue grew 5% to $64.5 million, with 12% growth in adult-use and 10% in international cannabis.
Distribution revenue increased 9% to $74 million, while wellness revenue rose 3% to $15.2 million.
Gross profit was $57.5 million (gross margin 27%), down from $59.7 million (30%) last year, due to lower margins in beverage and cannabis.
Adjusted EBITDA improved to $10.2 million from $9.3 million last year.
Outlook and guidance
Reaffirmed fiscal 2026 guidance for adjusted EBITDA between $62 and $72 million.
Expects continued growth in international cannabis as permit backlogs clear and regulatory reforms progress.
Anticipates further margin improvements and operational efficiencies in beverage and cannabis segments.
Management remains confident in long-term growth, citing opportunities in U.S. cannabis rescheduling and European market evolution.
Further realization of Project 420 synergies and ongoing investments in marketing and infrastructure for acquired brands expected.
Latest events from Tilray Brands
- Acquisition creates a $500M global craft beverage platform and accelerates international growth.TLRY
M&A announcement2 Mar 2026 - Balanced growth across cannabis, beverages, and distribution, with innovation and efficiency focus.TLRY
TD Cowen 9th Annual Future of the Consumer Conference3 Feb 2026 - Record revenue and EBITDA growth, margin gains, and strong outlook for continued expansion.TLRY
Q4 20242 Feb 2026 - Q1 revenue hit $200M (+13% YoY), led by beverage growth and margin gains, with net loss improvement.TLRY
Q1 202519 Jan 2026 - Q2 revenue hit $211M (+9% YoY), with margin gains and Project 420 synergies advancing.TLRY
Q2 202510 Jan 2026 - Record Q2 revenue, improved net loss, and net cash position; 2026 guidance reaffirmed.TLRY
Q2 20269 Jan 2026 - Diversified global platform drives growth in cannabis, beverage, and wellness with strong financials.TLRY
Investor Presentation8 Jan 2026 - Proxy covers director election, auditor ratification, pay, and board declassification proposals.TLRY
Proxy Filing2 Dec 2025 - Shareholders to vote on board declassification, share increase, and executive compensation reforms.TLRY
Proxy Filing2 Dec 2025